In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer.
Grzeskowiak CL, Kundu ST, Mo X, Ivanov AA, Zagorodna O, Lu H, Chapple RH, Tsang YH, Moreno D, Mosqueda M, Eterovic K, Fradette JJ, Ahmad S, Chen F, Chong Z, Chen K, Creighton CJ, Fu H, Mills GB, Gibbons DL, Scott KL.
Grzeskowiak CL, et al. Among authors: gibbons dl.
Nat Commun. 2018 Jul 16;9(1):2732. doi: 10.1038/s41467-018-04572-3.
Nat Commun. 2018.
PMID: 30013058
Free PMC article.